NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Pharmaceutical Retailers · USD

Pomdoctor Limited (POM) Stock Analysis

Pomdoctor Limited (POM) is a Pharmaceutical Retailers stock listed on NASDAQ and quoted in US Dollar.

POM

$0.83

−$0.04 (−4.60%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare POM with… →

POM Key Statistics

As of Sep 4, 2026
Trading
Open
$0.86
Previous Close
$0.87
Day's Range
0.83–0.90
52-Week Range
0.50–115.74
Volume
17.10K
Valuation
P/E Ratio
unprofitable
EPS (ttm)Profit attributable to each share over the last twelve months.
−6.04
Financials (FY)
Revenue (FY)
$399.91M+16.74%
Net Income (FY)
−$212.58M
Profit marginThe share of revenue left as profit after all costs and taxes.
−53.16%
Dividend and dates
Avg Volume
84.39K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

POM Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−84.37%
2025 (partial year)−92.68%

As of September 4, 2026.

POM Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$399.91M−$212.58M−53.2%
2024$342.56M−$143.36M−41.9%
2023$304.85M−$145.39M−47.7%
2022$245.22M−$125.51M−51.2%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$399.91M$52.28M−$116.37M−$212.58M−53.2%
2024$342.56M$47.69M−$23.36M−$143.36M−41.9%
2023$304.85M$38.72M−$20.32M−$145.39M−47.7%
2022$245.22M$54.86M−$3.31M−$125.51M−51.2%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

POM Valuation vs Pharmaceutical Retailers Median

Median of 6 stocks
MetricPOMPharmaceutical Retailers medianvs median
Profit margin−53.16%−11.95%41.2 pts below

Medians across 6 Pharmaceutical Retailers stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The record here covers Pomdoctor Limited, ticker POM. It is classified in the Pharmaceutical Retailers industry, within the Healthcare sector. Headcount on file is 165.

The most recent close on file for POM is $0.83, dated September 4, 2026. That is −$0.04 (−4.60%) against the previous close. The 52-week range on file runs from $0.50 to $115.74. The latest close sits 66% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $399.91M. That is +16.74% against the prior fiscal year, when revenue was $342.56M. The same year closed with a net loss of $212.58M. Profit margin runs at −53.16%. That is 41.2 percentage points below the Pharmaceutical Retailers median of −11.95%. Earnings per share on a trailing basis come to −6.04.

Across the 4 fiscal years on file, revenue moves from $245.22M in 2022 to $399.91M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative.

The stored price history starts on October 8, 2025, and the total return since then is −98.86%.

Growth & Income

No dividend is on file for POM.

So far in 2026 the price is −84.37%.

Peer Comparison

Pomdoctor Limited (POM) operates in the Pharmaceutical Retailers industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Pomdoctor Limited POM — —
High Tide Inc. HITI $225.39M —
TelyRx Holdings Inc. TELY.TO $65.15M —
PetMed Express, Inc. PETS $39.24M —

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Pharmaceutical Retailers Stocks

HITI

High Tide Inc.

$225.39M

 TELY.TO

TelyRx Holdings Inc.

$65.15M

 PETS

PetMed Express, Inc.

$39.24M

 SCNX

Scienture Holdings, Inc.

$15.32M

 RDGT

Ridgetech, Inc.

$3.30M
View all Pharmaceutical Retailers stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Pomdoctor Limited

Pomdoctor Limited, through its subsidiaries, offers an online B2C portal to sell pharmaceutical products. The company develops an online medical services platform for chronic diseases in China. The company focuses on chronic disease management and pharmaceutical services and offers platform for medical services, which connects patients to doctors and pharmaceutical products. The company in involved in internet hospital and pharmaceutical supply chain, connecting users, pharmacies, suppliers, medical professionals, and other healthcare participants. The company was founded in 2010 and is headquartered in Guangzhou, China.

Visit website →